The question of how best to assess and advise on the safety of passengers with lung disease planning air travel is an increasingly common one faced by respiratory physicians and other healthcare professionals. Since Therefore, physicians must be aware of the potential effects of the flight environment in those with lung disease, and the need for practical recommendations remains.
The 2011 guidance document now covers bronchiectasis, cancer, obesity, hyperventilation and dysfunctional breathing, pulmonary arteriovenous malformations and sinus and middle ear disease; and has expanded sections on infection and co-morbidity with cardiac disease. The recommendations are an expert consensus view based on literature reviews and aim to provide practical advice for respiratory specialists in secondary care, as well as providing a valuable reference for other healthcare professionals. The advice applies to commercial flights only (including scheduled repatriation with a medical or nurse escort), and excludes emergency aeromedical evacuations. However, if medical practitioners do assist at an in-flight medical emergency, most airlines will indemnify them, the aircraft will have medical equipment and they can often access specialist advice from ground-based support.
PURPOSE OF RECOMMENDATIONS
< To enhance safety for passengers with lung disease travelling on commercial flights and reduce respiratory complications. < To promote further understanding among healthcare professionals that patients with respiratory disease may require clinical assessment and advice before air travel. < To provide an authoritative up-to-date literature review of the latest available evidence. < To provide consistent, practical and comprehensive advice for healthcare professionals managing these patients. < To formulate key research questions to provoke further investigation, thereby providing a strengthened high quality evidence base for future guidelines. < To promote the development of methods for monitoring the size of the problem. A summary of key points from the new recommendations (table 1) and an algorithm for managing adult passengers with respiratory disease planning air travel (figure 1) are included here for practical reference in the clinic setting.
